Year |
Citation |
Score |
2023 |
Simpson CE, Ambade AS, Harlan R, Roux A, Aja S, Graham D, Shah AA, Hummers LK, Hemnes AR, Leopold JA, Horn EM, Berman-Rosenzweig ES, Grunig G, Aldred MA, Barnard J, et al. Kynurenine pathway metabolism evolves with development of preclinical and scleroderma-associated pulmonary arterial hypertension. American Journal of Physiology. Lung Cellular and Molecular Physiology. 325: L617-L627. PMID 37786941 DOI: 10.1152/ajplung.00177.2023 |
0.318 |
|
2023 |
Simpson CE, Ambade AS, Harlan R, Roux A, Graham D, Klauer N, Tuhy T, Kolb TM, Suresh K, Hassoun PM, Damico RL. Spatial and temporal resolution of metabolic dysregulation in the Sugen hypoxia model of pulmonary hypertension. Pulmonary Circulation. 13: e12260. PMID 37404901 DOI: 10.1002/pul2.12260 |
0.332 |
|
2023 |
Simpson CE, Hemnes AR, Griffiths M, Grunig G, Tang WHW, Garcia JGN, Barnard J, Comhair SA, Damico RL, Mathai SC, Hassoun PM. Metabolomic differences in connective tissue disease-associated versus idiopathic pulmonary arterial hypertension in the PVDOMICS cohort. Arthritis & Rheumatology (Hoboken, N.J.). PMID 37335853 DOI: 10.1002/art.42632 |
0.37 |
|
2023 |
Philip N, Pi H, Gadkari M, Yun X, Huetsch J, Zhang C, Harlan R, Roux A, Graham D, Shimoda L, Le A, Visovatti S, Leary PJ, Gharib SA, Simpson C, et al. Transpulmonary amino acid metabolism in the sugen hypoxia model of pulmonary hypertension. Pulmonary Circulation. 13: e12205. PMID 36873460 DOI: 10.1002/pul2.12205 |
0.322 |
|
2022 |
Naranjo M, Mercurio V, Hassan H, Alturaif N, Cuomo A, Attanasio U, Diab N, Sahetya SK, Mukherjee M, Hsu S, Balasubramanian A, Simpson CE, Damico R, Kolb TM, Mathai SC, et al. Causes and outcomes of ICU hospitalisations in patients with pulmonary arterial hypertension. Erj Open Research. 8. PMID 35586454 DOI: 10.1183/23120541.00002-2022 |
0.305 |
|
2022 |
Simpson CE, Kolb TM, Hsu S, Zimmerman SL, Corona-Villalobos CP, Mathai SC, Damico RL, Hassoun PM. Ventricular mass discriminates pulmonary arterial hypertension as redefined at the Sixth World Symposium on Pulmonary Hypertension. Pulmonary Circulation. 12: e12005. PMID 35506079 DOI: 10.1002/pul2.12005 |
0.304 |
|
2021 |
Daly CM, Griffiths M, Simpson CE, Yang J, Damico RL, Vaidya RD, Williams M, Brandal S, Jone PN, Polsen C, Ivy DD, Austin ED, Nichols WC, Pauciulo MW, Lutz K, et al. Angiostatic Peptide, Endostatin, Predicts Severity in Pediatric Congenital Heart Disease-Associated Pulmonary Hypertension. Journal of the American Heart Association. e021409. PMID 34622662 DOI: 10.1161/JAHA.120.021409 |
0.314 |
|
2021 |
Griffiths M, Yang J, Simpson CE, Vaidya D, Nies M, Brandal S, Damico R, Ivy D, Austin ED, Pauciulo MW, Lutz KA, Rosenzweig EB, Hirsch R, Yung D, Nichols WC, et al. ST2 is a biomarker of pediatric pulmonary arterial hypertension severity and clinical worsening. Chest. PMID 33609516 DOI: 10.1016/j.chest.2021.01.085 |
0.354 |
|
2020 |
Chen JY, Griffiths M, Yang J, Nies MK, Damico RL, Simpson CE, Vaidya RD, Brandal S, Ivy DD, Austin ED, Nichols WC, Pauciulo MW, Lutz K, Rosenzweig EB, Hirsch R, et al. Elevated Interleukin-6 Levels Predict Clinical Worsening in Pediatric Pulmonary Arterial Hypertension. The Journal of Pediatrics. 223: 164-169.e1. PMID 32711743 DOI: 10.1016/J.Jpeds.2020.04.041 |
0.318 |
|
2020 |
Simpson CE, Damico RL, Hassoun PM, Martin LJ, Yang J, Nies MK, Vaidya RD, Brandal S, Pauciulo MW, Austin ED, Ivy DD, Nichols WC, Everett AD. Noninvasive prognostic biomarkers for left heart failure as predictors of survival in pulmonary arterial hypertension. Chest. PMID 31987881 DOI: 10.1016/J.Chest.2019.12.037 |
0.32 |
|
2019 |
Simpson CE, Damico RL, Hummers L, Khair RM, Kolb TM, Hassoun PM, Mathai SC. Serum uric acid as a marker of disease risk, severity, and survival in systemic sclerosis-related pulmonary arterial hypertension. Pulmonary Circulation. 9: 2045894019859477. PMID 31384431 DOI: 10.1177/2045894019859477 |
0.322 |
|
Show low-probability matches. |